Skip to main content
Premium Trial:

Request an Annual Quote

Thomas D'Alonzo, Alene Campbell

Premium
BioDelivery Sciences has appointed Thomas D’Alonzo to its board of directors.
 
D’Alonzo has held positions, including president, at Glaxo, the US subsidiary of the former Glaxo Holdings. He was also president and CEO of GenVec.
 

 
BaroFold has appointed Alene Campbell as its chief business officer.
 
Previously, Campbell was vice president of corporate development at Myogen. Before this, she was vice president of corporate development at Ribozyme Pharmaceuticals, now Sirna Therapeutics.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.